Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Further research is needed to develop effective cancer prevention strategies.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Upadacitinib may cause hair loss.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The treatment combination is effective and generally safe for lung cancer.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.